Nonetheless, resistance is acquired and correlates with an increased expression of NRG1. By trying to overcome it, adding pertuzumab has shown promising results in decreasing NRG1-acquired resistance and tumor progression (25). This evidence concerns the gene NRG1 and neoplasm.